ACR 99: Scleroderma Awareness Day.
- Session Year: 2025-2026
- House: Assembly
- Latest Version Date: 2025-07-24
Current Status:
Passed
(2025-07-24: Chaptered by Secretary of State - Res. Chapter 154, Statutes of 2025.)
Introduced
In Committee
Awaiting First Chamber Vote
Passed First Chamber
In Committee
Awaiting Second Chamber Vote
Passed Second Chamber
Enacted
This measure would declare June 29, 2025, as Scleroderma Awareness Day in California.
This measure would declare June 29, 2025, as Scleroderma Awareness Day in California.
This measure would declare June 29, 2025, as Scleroderma Awareness Day in California.
WHEREAS, Scleroderma is a chronic, systemic autoimmune disease primarily characterized by the hardening of the skin, its hallmark symptom, but its impact can extend far beyond the skin to involve internal organs, which can lead to severe complications; and
WHEREAS, Scleroderma is distinguished into two main types: localized scleroderma, which mainly affects the skin, and systemic sclerosis, which can affect large areas of skin and vital organs, including the heart, lungs, kidneys, and gastrointestinal tract; and
WHEREAS, The exact causes of scleroderma remain unclear, but it is thought to arise from a combination of genetic and environmental factors, leading to an overproduction of collagen; and
WHEREAS, Statistically, scleroderma affects approximately 300,000 Americans, of which 80 percent are women who are usually between the ages of 30 and 50, although it can manifest at any age; and
WHEREAS, The diversity in symptoms and severity makes scleroderma a particularly challenging disease to diagnose and manage, often requiring a multidisciplinary approach to treatment that includes rheumatologists, dermatologists, and other specialists; and
WHEREAS, The impact of scleroderma is profound due to the progressive nature of the disease and its effect on multiple body systems; and
WHEREAS, The psychological and socio-economic impacts of scleroderma on patients and their families are considerable, affecting quality of life and daily functioning; and
WHEREAS, In the State of California, recognizing the need for increased awareness and support for scleroderma is crucial; and
WHEREAS, The Scleroderma Foundation of California funds education and awareness programs with a mission to empower the scleroderma community to live their best lives through programs dedicated to support, education, and research; and
WHEREAS, The establishment of Scleroderma Awareness Day aims to enhance public understanding of the disease, promote early diagnosis and treatment, and mobilize community resources and support for those affected; now, therefore, be it
Resolved by the Assembly of the State of California, the Senate thereof concurring, That the Legislature hereby declares June 29, 2025, as Scleroderma Awareness Day in California, acknowledges the significant challenges faced by individuals living with scleroderma, and affirms the states support for medical research and advocacy efforts aimed at combating this debilitating disease; and be it further
Resolved, That the declaration of June 29, 2025, as Scleroderma Awareness Day in California reflects the states commitment to public health and the well-being of its constituents; and be it further
Resolved, That the Chief Clerk of the Assembly transmit copies of this resolution to the author for appropriate distribution.
WHEREAS, Scleroderma is a chronic, systemic autoimmune disease primarily characterized by the hardening of the skin, its hallmark symptom, but its impact can extend far beyond the skin to involve internal organs, which can lead to severe complications; and
WHEREAS, Scleroderma is distinguished into two main types: localized scleroderma, which mainly affects the skin, and systemic sclerosis, which can affect large areas of skin and vital organs, including the heart, lungs, kidneys, and gastrointestinal tract; and
WHEREAS, The exact causes of scleroderma remain unclear, but it is thought to arise from a combination of genetic and environmental factors, leading to an overproduction of collagen; and
WHEREAS, Statistically, scleroderma affects approximately 300,000 Americans, of which 80 percent are women who are usually between the ages of 30 and 50, although it can manifest at any age; and
WHEREAS, The diversity in symptoms and severity makes scleroderma a particularly challenging disease to diagnose and manage, often requiring a multidisciplinary approach to treatment that includes rheumatologists, dermatologists, and other specialists; and
WHEREAS, The impact of scleroderma is profound due to the progressive nature of the disease and its effect on multiple body systems; and
WHEREAS, The psychological and socio-economic impacts of scleroderma on patients and their families are considerable, affecting quality of life and daily functioning; and
WHEREAS, In the State of California, recognizing the need for increased awareness and support for scleroderma is crucial; and
WHEREAS, The Scleroderma Foundation of California funds education and awareness programs with a mission to empower the scleroderma community to live their best lives through programs dedicated to support, education, and research; and
WHEREAS, The establishment of Scleroderma Awareness Day aims to enhance public understanding of the disease, promote early diagnosis and treatment, and mobilize community resources and support for those affected; now, therefore, be it
Resolved by the Assembly of the State of California, the Senate thereof concurring, That the Legislature hereby declares June 29, 2025, as Scleroderma Awareness Day in California, acknowledges the significant challenges faced by individuals living with scleroderma, and affirms the states support for medical research and advocacy efforts aimed at combating this debilitating disease; and be it further
Resolved, That the declaration of June 29, 2025, as Scleroderma Awareness Day in California reflects the states commitment to public health and the well-being of its constituents; and be it further
Resolved, That the Chief Clerk of the Assembly transmit copies of this resolution to the author for appropriate distribution.
WHEREAS, Scleroderma is a chronic, systemic autoimmune disease primarily characterized by the hardening of the skin, its hallmark symptom, but its impact can extend far beyond the skin to involve internal organs, which can lead to severe complications; and
WHEREAS, Scleroderma is distinguished into two main types: localized scleroderma, which mainly affects the skin, and systemic sclerosis, which can affect large areas of skin and vital organs, including the heart, lungs, kidneys, and gastrointestinal tract; and
WHEREAS, The exact causes of scleroderma remain unclear, but it is thought to arise from a combination of genetic and environmental factors, leading to an overproduction of collagen; and
WHEREAS, Statistically, scleroderma affects approximately 300,000 Americans, of which 80 percent are women who are usually between the ages of 30 and 50, although it can manifest at any age; and
WHEREAS, The diversity in symptoms and severity makes scleroderma a particularly challenging disease to diagnose and manage, often requiring a multidisciplinary approach to treatment that includes rheumatologists, dermatologists, and other specialists; and
WHEREAS, The impact of scleroderma is profound due to the progressive nature of the disease and its effect on multiple body systems; and
WHEREAS, The psychological and socio-economic impacts of scleroderma on patients and their families are considerable, affecting quality of life and daily functioning; and
WHEREAS, In the State of California, recognizing the need for increased awareness and support for scleroderma is crucial; and
WHEREAS, The Scleroderma Foundation of California funds education and awareness programs with a mission to empower the scleroderma community to live their best lives through programs dedicated to support, education, and research; and
WHEREAS, The establishment of Scleroderma Awareness Day aims to enhance public understanding of the disease, promote early diagnosis and treatment, and mobilize community resources and support for those affected; now, therefore, be it
Resolved by the Assembly of the State of California, the Senate thereof concurring, That the Legislature hereby declares June 29, 2025, as Scleroderma Awareness Day in California, acknowledges the significant challenges faced by individuals living with scleroderma, and affirms the states support for medical research and advocacy efforts aimed at combating this debilitating disease; and be it further
Resolved, That the declaration of June 29, 2025, as Scleroderma Awareness Day in California reflects the states commitment to public health and the well-being of its constituents; and be it further
Resolved, That the Chief Clerk of the Assembly transmit copies of this resolution to the author for appropriate distribution.
|
Date
|
Status
|
|---|---|
| Jul 24, 2025 | Chaptered by Secretary of State - Res. Chapter 154, Statutes of 2025. |
| Jul 24, 2025 | Enrolled and filed with the Secretary of State at 1 p.m. |
| Jul 17, 2025 | In Assembly. Ordered to Engrossing and Enrolling. |
| Jul 17, 2025 | Adopted and to Assembly. (Ayes 35. Noes 0. Page 2139.) |
| Jul 15, 2025 | Ordered to special consent calendar. |
| Jul 9, 2025 | From committee: Ordered to third reading. |
| Jun 30, 2025 | In Senate. To Com. on RLS. |
| Jun 27, 2025 | Adopted and to Senate. (Ayes 75. Noes 0. Page 2341.) |
| Jun 27, 2025 | Coauthors revised. |
| Jun 23, 2025 | From committee: Be adopted. To Consent Calendar. (Ayes 10. Noes 0.) (June 23). |
| Jun 23, 2025 | Referred to Com. on RLS. |
| Jun 17, 2025 | From printer. |
| Jun 16, 2025 | Introduced. To print. |
|
Date
|
Description
|
Location
|
Votes
|
|
|---|---|---|---|---|
| Jul 17, 2025 | Special Consent ACR99 Davies et al. | Senate Floor |
Passed |
|
| Jun 27, 2025 | ACR 99 Davies Consent Calendar Second Day Regular Session | Assembly Floor |
Passed |
|
| Jun 23, 2025 | Be adopted. To Consent Calendar. | Assembly Standing Committee on Rules |
Passed |
This list shows positions taken on this bill by organizations on the date displayed, which is linked to the original source.
Positions by individuals are not included.
SENATE RULES COMMITTEE Office of Senate Floor Analyses (916) 651-1520 Fax: (916) 327-4478 | ACR 99 |
THIRD READING
Bill No: ACR 99
Author: Davies (R), et al.
Introduced: 6/16/25
Vote: 21
ASSEMBLY FLOOR: 75-0, 6/27/25 (Consent) - See last page for vote
SUBJECT: Scleroderma Awareness Day
SOURCE: Author
DIGEST:
This resolution declares June 29, 2025, as Scleroderma Awareness Day in California.
ANALYSIS: This resolution makes the following legislative findings:
- Scleroderma is a chronic, systemic autoimmune disease primarily characterized by the hardening of the skin, its hallmark symptom, but its impact can extend far beyond the skin to involve internal organs, which can lead to severe complications.
- Statistically, scleroderma affects approximately 300,000 Americans, of which 80% are women who are usually between the ages of 30 and 50, although it can manifest at any age.
- The psychological and socio-economic impacts of scleroderma on patients and their families are considerable, affecting quality of life and daily functioning.
- The Scleroderma Foundation of California funds education and awareness programs with a mission to empower the scleroderma community to live their best lives through programs dedicated to support, education, and research.
This resolution declares of June 29, 2025, as Scleroderma Awareness Day in California reflects the state’s commitment to public health and the well-being of its constituents.
FISCAL EFFECT: Appropriation: No Fiscal Com.: No Local: No
SUPPORT: (Verified 7/8/25)
None received
OPPOSITION: (Verified 7/8/25)
None received
ASSEMBLY FLOOR: 75-0, 6/27/25
AYES: Addis, Aguiar-Curry, Ahrens, Alanis, Alvarez, Arambula, Ávila Farías, Bains, Bennett, Berman, Boerner, Bonta, Bryan, Calderon, Caloza, Carrillo, Castillo, Chen, Connolly, Davies, DeMaio, Dixon, Elhawary, Ellis, Fong, Gabriel, Gallagher, Garcia, Gipson, Jeff Gonzalez, Mark González, Hadwick, Haney, Harabedian, Hart, Hoover, Irwin, Jackson, Kalra, Krell, Lackey, Lee, Lowenthal, Macedo, McKinnor, Muratsuchi, Nguyen, Ortega, Pacheco, Papan, Patel, Patterson, Petrie-Norris, Quirk-Silva, Ramos, Ransom, Celeste Rodriguez, Michelle Rodriguez, Rogers, Sanchez, Schiavo, Schultz, Sharp-Collins, Solache, Soria, Stefani, Ta, Tangipa, Valencia, Wallis, Ward, Wicks, Wilson, Zbur, Rivas
NO VOTE RECORDED: Bauer-Kahan, Flora, Pellerin, Blanca Rubio
Prepared by: Sofia Pachon-Mendez / SFA / (916) 651-1520
7/9/25 16:03:39
**** END ****
Date of Hearing: June 23, 2025
ASSEMBLY COMMITTEE ON RULES
Blanca Pacheco, Chair
ABPCA Bill Id:ACR 99 (
Author:Davies) – As Introduced Ver:June 16, 2025
SUBJECT: Scleroderma Awareness Day.
SUMMARY: Declares June 29, 2025, as Scleroderma Awareness Day in California to reflect the state’s commitment to public health and the well-being of its constituents. Specifically, this resolution makes the following legislative findings:
- Scleroderma is a chronic, systemic autoimmune disease primarily characterized by the hardening of the skin, its hallmark symptom, but its impact can extend far beyond the skin to involve internal organs, which can lead to severe complications.
- Scleroderma is distinguished into two main types: localized scleroderma, which mainly affects the skin, and systemic sclerosis, which can affect large areas of skin and vital organs, including the heart, lungs, kidneys, and gastrointestinal tract.
- The exact causes of scleroderma remain unclear, but it is thought to arise from a combination of genetic and environmental factors, leading to an overproduction of collagen.
- The diversity in symptoms and severity makes scleroderma a particularly challenging disease to diagnose and manage, often requiring a multidisciplinary approach to treatment that includes rheumatologists, dermatologists, and other specialists.
- The impact of scleroderma is profound due to the progressive nature of the disease and its effect on multiple body systems. The psychological and socio-economic impacts of scleroderma on patients and their families are considerable, affecting quality of life and daily functioning.
- The establishment of Scleroderma Awareness Day aims to enhance public understanding of the disease, promote early diagnosis and treatment, and mobilize community resources and support for those affected.
FISCAL EFFECT: This resolution is keyed non-fiscal by Legislative Counsel.
REGISTERED SUPPORT / OPPOSITION:
Support
None on file
Opposition
None on file
Analysis Prepared by: Michael Erke / RLS. / (916) 319-2800
Bill Author
Bill Co-Author(s):